Category Medicine and Healthcare
Press Release
Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability
FY24 revenue up 25.2% YOY FY24 margins improved 1280 basis points to 69.3%, from 56.5% in the prior year; Q4-FY24 margins improved to 71.5%; margin expansion forecasted to continue FY24 operating expenses lower by 17.6% YOY Negative EBITDA reduced by $7.2 million - an improvement of 44.6% -- accelerating the Company's path to breakeven and EBITDA positive Read More
Press Release
Dante Genomics Generative AI GenomeChat Aims at Becoming Doctors’ and Patients’ Best Partner for Advanced Genomics Solutions
The first-in-class GenAI Platform Dante GenomeChat was presented to a private audience at Amazon Web Services Health Summit in Amsterdam, showcasing how it leverages billions of parameters and Dante Genomics expertise to provide doctors with prioritised and personalized insights Read More
Press Release
Freyja Healthcare Secures $8M in New Funding and Appoints Tracy MacNeal as Independent Board Director
Fresh financing to continue development of robust product portfolio and accelerate commercialization of Freyja's VereSee Device to further innovation in fast-growing women's health market Read More
Press Release
Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea and oral mucositis In honor of World Rainforest Day (June 22), Jaguar is proud to share RealPharma podcast interview with ethnobotanist Dr. Steven King Read More
Press Release
The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders
The online learning program reflects organization's dedication to empowering individuals and families affected by these conditions with knowledge and support Read More
Press Release
Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis
FDA Provides Positive Feedback to Company Regarding TH104 Phase 2 Program Company Incorporating FDA Feedback into Phase 2 Protocol Company Believes it is On-track to Initiate Phase 2 Trial Read More
Press Release
Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the American Diabetes Association Annual Meeting in Orlando, June 21-24. Read More
Press Release
Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA
Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testing Next-Gen Ainos Flora will advance with NVIDIA CUDA, targeting Q3 for design completion and Q4 for clinical trial kickoff Read More
Press Release
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older Read More
Press Release
